COMP <GO>
PATH vs NICE // RETURN ON INVESTED CAPITAL (ROIC)
UiPath Inc. (NYSE) VS. NICE Ltd (NASDAQ) • 15-METRIC TALLY: PATH 4
— NICE 8
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: NICE
LAST: $13.34 (-2.84%) • MKT CAP: $6.95B
roic
2.70%
LAST: $112.39 (-1.20%) • MKT CAP: $6.68B
roic
11.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PATH VS. NICE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PATH | NICE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 83.20% | 66.40% | +16.80 | PATH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 2.70% | 11.30% | -8.60 | NICE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 92.8x | 11.3x | +81.50 | NICE | /valuation <GO> |
| Free Cash Flow Yield | 4.90% | 10.21% | -5.31 | NICE | /fcf-yield <GO> |
| Operating Margin | 3.50% | 21.90% | -18.40 | NICE | /operating-margins <GO> |
| Net Profit Margin | 17.50% | 20.80% | -3.30 | NICE | /net-margins <GO> |
| Revenue Growth (YoY) | 12.70% | 7.70% | +5.00 | PATH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.25 | 3.69 | +0.56 | PATH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 9/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.5 | 45.8 | -1.30 | NICE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.21 | 1.27 | -0.06 | NICE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.3x | 10.4x | +10.90 | NICE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.95B | $6.68B | $275.8M | PATH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PATH REV | NICE REV | PATH GROSS % | NICE GROSS % | PATH FCF | NICE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.61B | $2.95B | 83.2% | 66.4% | $352.2M | $697.6M |
| FY 2024 | $1.43B | $2.74B | 82.7% | 66.7% | $305.6M | $797.7M |
| FY 2023 | $1.31B | $2.38B | — | — | $240.2M | $454.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PATH // BETA 1.21
NICE // BETA 1.27